Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers-Reference-Cited by-同舟云学术

Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers

Published:2013-08-06 Issue:1 Volume:231 Page:130-141
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Krohn Antje¹,Seidel Annemarie¹,Burkhardt Lia¹,Bachmann Frederic¹,Mader Malte²,Grupp Katharina³,Eichenauer Till⁴,Becker Andreas⁴,Adam Meike⁴,Graefen Markus⁴,Huland Hartwig⁴,Kurtz Stefan²,Steurer Stefan¹,Tsourlakis Maria C¹,Minner Sarah¹,Michl Uwe⁴,Schlomm Thorsten⁴⁵,Sauter Guido¹,Simon Ronald¹,Sirma Hüseyin¹

Affiliation:

1. Institute of Pathology; University Medical Centre Hamburg-Eppendorf; Hamburg Germany

2. Centre for Bioinformatics; University of Hamburg; Germany

3. Department of Surgery; University Medical Centre Hamburg-Eppendorf; Hamburg Germany

4. Martini-Clinic Prostate Cancer Centre; University Medical Centre Hamburg-Eppendorf; Hamburg Germany

5. Department of Urology; Section for Translational Prostate Cancer Research at University Medical Centre Hamburg-Eppendorf; Hamburg Germany

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/path.4223/fullpdf

Reference49 articles.

1. Cancer statistics, 2010;Jemal;CA Cancer J Clinicians,2010

2. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer;Tomlins;Science,2005

3. Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome;Yoshimoto;Mod Pathol,2008

4. Genomic deletion of PTEN is associated with tumor progression and early PSA recurrence in ERG fusion-positive and fusion-negative prostate cancer;Krohn;Am J Pathol,2012

5. Distinct genomic alterations in prostate cancers in Chinese and Western populations suggest alternative pathways of prostate carcinogenesis;Mao;Cancer Res,2010

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the Binding between the Armadillo-Repeat Domain of Plakophilin 1 and the Intrinsically Disordered Transcriptional Repressor RYBP;Biomolecules;2024-05-07

2. Acute myeloid leukemia with unreported translocation (x; 3) (q24; p13): A case report;Clinical Case Reports;2024-02

3. The intrinsically disordered, epigenetic factor RYBP binds to the citrullinating enzyme PADI4 in cancer cells;International Journal of Biological Macromolecules;2023-08

4. ETS factors in prostate cancer;Cancer Letters;2022-04

5. Kolorektal Kanserde RYBP ve MDM2 Genlerinin Ekspresyon Düzeylerindeki Değişimi;Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi;2022-03-31